Mymetics (QB) Stock Price

-0.0084 (-15.73%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Mymetics Corporation (QB) MYMX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0084 -15.73% 0.045 0.045 0.0533 0.051155 0.0534 15:36:26
Bid Price Ask Price Spread Spread % News
0.045 0.0533 0.0083 15.57% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7 73,234 $ 0.050305 $ 3,684 183,794 0.0211 - 0.0654
Last Trade Time Type Quantity Stock Price Currency
15:36:26 470 $ 0.045 USD

Mymetics (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 13.67M 303.76M 79.56M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
82.03k $ - 0.00% - -

more financials information »

Mymetics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYMX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.040.05350.040.049964399,6090.00512.5%
1 Month0.050.0650.03770.0500764191,011-0.005-10.0%
3 Months0.0250.06540.02110.0444703194,6430.0280.0%
6 Months0.0320.06540.02110.0420534129,2070.01340.63%
1 Year0.03740.06540.02110.041077195,7430.007620.32%
3 Years0.02560.0950.01550.0443856232,3240.019475.78%
5 Years0.0240.0950.0080.0386953201,5810.02187.5%

Mymetics (QB) Description

Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. Mymetics currently has the following vaccines in its pipeline: HIV/AIDS. intranasal Influenza, RSV, Malaria and Chikungunya and collaboration projects in the allergy and cancer immunotherapy field.

Your Recent History
Mymetics (..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.